1. Dean DS, Hay ID. Prognostic indicators in differentiated thyroid carcinoma. Cancer Control. 2000;7(3):229-239. doi:10.1177/107327480000700302
2. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97(5):418-428. http://www.ncbi.nlm.nih.gov/pubmed/7977430. Accessed January 5, 2019.
3. G. P, F. F, C. R, S. S, R. V. Worldwide increasing incidence of thyroid cancer: Update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013. doi:10.1155/2013/965212
4. Du L, Wang Y, Sun X, et al. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China. BMC Cancer. 2018;18(1):291. doi:10.1186/s12885-018-4081-7
5. Neta G, Rajaraman P, Berrington De Gonzalez A, et al. A prospective study of medical diagnostic radiography and risk of thyroid cancer. Am J Epidemiol. 2013;177(8):800-809. doi:10.1093/aje/kws315
6. Schonfeld SJ, Lee C, Berrington de González A. Medical Exposure to Radiation and Thyroid Cancer. Clin Oncol. 2011;23(4):244-250. doi:10.1016/j.clon.2011.01.159
7. Park HS, Baek JH, Park AW, Chung SR, Choi YJ, Lee JH. Thyroid radiofrequency ablation: Updates on innovative devices and techniques. Korean J Radiol. 2017;18(4):615-623. doi:10.3348/kjr.2017.18.4.615
8. Soh EY, Sobhi SA, Wong MG, et al. Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines. Surgery. 1996;120(6):944-947. http://www.ncbi.nlm.nih.gov/pubmed/8957478. Accessed January 7, 2019.
9. Hyperthyroidism – Symptoms and causes – Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/hyperthyroidism/symptoms-causes/syc-20373659. Accessed January 15, 2019.
10. Lee J-H, Kim Y, Choi J-W, Kim Y-S. The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis. Eur J Endocrinol. 2013;168(3):343-349. doi:10.1530/EJE-12-0903